On the other hand, overexpression of some specific enzymes, e.g., cyclin-dependent kinases (CDK4, CDK6, and CDK2), polo-like kinase 1 (PLK1), and aurora kinases (aurora A and aurora B), can induce or contribute to tumorigenesis, which drives cancer progression [10,11]. This evidence concerns the gene PLK1 and cancer.